rs779040832
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000137.4(FAH):c.1025C>T(p.Pro342Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,609,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P342P) has been classified as Likely benign.
Frequency
Consequence
NM_000137.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAH | NM_000137.4 | c.1025C>T | p.Pro342Leu | missense_variant | 12/14 | ENST00000561421.6 | |
FAH | NM_001374377.1 | c.1025C>T | p.Pro342Leu | missense_variant | 13/15 | ||
FAH | NM_001374380.1 | c.1025C>T | p.Pro342Leu | missense_variant | 13/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAH | ENST00000561421.6 | c.1025C>T | p.Pro342Leu | missense_variant | 12/14 | 1 | NM_000137.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247034Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134056
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1457358Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 725216
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74448
ClinVar
Submissions by phenotype
Tyrosinemia type I Pathogenic:5
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 02, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 01, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 342 of the FAH protein (p.Pro342Leu). This variant is present in population databases (rs779040832, gnomAD 0.003%). This missense change has been observed in individual(s) with tyrosinemia type 1 (PMID: 8005583, 8829657, 9633815, 30414057). ClinVar contains an entry for this variant (Variation ID: 551024). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FAH protein function. Experimental studies have shown that this missense change affects FAH function (PMID: 8005583). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 07, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at